Farhad Ravandi, Ellen K. Ritchie, Hamid Sayar, Jeffrey E. Lancet, Michael D. Craig, Norbert Vey, Stephen A. Strickland, Gary J. Schiller, Elias Jabbour, Arnaud Pigneux, Heinz-August Horst, Christian Récher, Virginia M. Klimek, Jorge E. Cortes, Angelo-Michele Carella, Miklos Egyed, Utz Krug, Judith A. Fox, Adam R. Craig, Renee Ward, Jennifer A. Smith, Gary Acton, Hagop M. Kantarjian, and Robert K. Stuart. 2018. “Phase 3 Results for vosaroxin/cytarabine in the Subset of Patients ≥60 Years Old With refractory/Early Relapsed Acute Myeloid Leukemia”. Haematologica 103 (11). Pavia, Italy, e514-e518. https://doi.org/10.3324/haematol.2018.191361.